DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,764 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $403,780 | +6.2% | 1,616 | +6.2% | 0.04% | +2.4% |
Q1 2024 | $380,074 | +16.3% | 1,522 | +7.7% | 0.04% | +5.1% |
Q4 2023 | $326,884 | +10.3% | 1,413 | +18.3% | 0.04% | 0.0% |
Q3 2023 | $296,232 | +3.9% | 1,194 | +0.5% | 0.04% | +2.6% |
Q2 2023 | $285,120 | +5.1% | 1,188 | +10.4% | 0.04% | +2.7% |
Q1 2023 | $271,196 | -5.2% | 1,076 | -0.2% | 0.04% | -7.5% |
Q4 2022 | $286,123 | +7.2% | 1,078 | +4.2% | 0.04% | -2.4% |
Q3 2022 | $267,000 | +1.9% | 1,035 | 0.0% | 0.04% | +10.8% |
Q2 2022 | $262,000 | -12.7% | 1,035 | +1.2% | 0.04% | -9.8% |
Q1 2022 | $300,000 | -40.6% | 1,023 | -33.4% | 0.04% | -33.9% |
Q4 2021 | $505,000 | +7.0% | 1,535 | -0.9% | 0.06% | 0.0% |
Q3 2021 | $472,000 | +13.5% | 1,549 | 0.0% | 0.06% | +12.7% |
Q2 2021 | $416,000 | +19.2% | 1,549 | 0.0% | 0.06% | +14.6% |
Q1 2021 | $349,000 | +5.4% | 1,549 | +4.0% | 0.05% | -2.0% |
Q4 2020 | $331,000 | +3.1% | 1,490 | -0.1% | 0.05% | -5.8% |
Q3 2020 | $321,000 | +19.8% | 1,492 | -1.5% | 0.05% | +8.3% |
Q2 2020 | $268,000 | +27.0% | 1,514 | -0.5% | 0.05% | +6.7% |
Q1 2020 | $211,000 | – | 1,522 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |